rs143878016

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001034850.3(RETREG1):​c.607G>A​(p.Val203Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0046 in 1,611,312 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0048 ( 17 hom. )

Consequence

RETREG1
NM_001034850.3 missense

Scores

5
12

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.214
Variant links:
Genes affected
RETREG1 (HGNC:25964): (reticulophagy regulator 1) The protein encoded by this gene is a cis-Golgi transmembrane protein that may be necessary for the long-term survival of nociceptive and autonomic ganglion neurons. Mutations in this gene are a cause of hereditary sensory and autonomic neuropathy type IIB (HSAN IIB), and this gene may also play a role in susceptibility to vascular dementia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011584997).
BP6
Variant 5-16481072-C-T is Benign according to our data. Variant chr5-16481072-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 245600.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-16481072-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00297 (452/152070) while in subpopulation NFE AF= 0.00496 (337/67948). AF 95% confidence interval is 0.00452. There are 2 homozygotes in gnomad4. There are 209 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RETREG1NM_001034850.3 linkuse as main transcriptc.607G>A p.Val203Met missense_variant 5/9 ENST00000306320.10 NP_001030022.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RETREG1ENST00000306320.10 linkuse as main transcriptc.607G>A p.Val203Met missense_variant 5/91 NM_001034850.3 ENSP00000304642 Q9H6L5-1

Frequencies

GnomAD3 genomes
AF:
0.00297
AC:
452
AN:
151952
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000701
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00328
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00496
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.00324
AC:
806
AN:
248472
Hom.:
1
AF XY:
0.00341
AC XY:
459
AN XY:
134792
show subpopulations
Gnomad AFR exome
AF:
0.00110
Gnomad AMR exome
AF:
0.00317
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00242
Gnomad FIN exome
AF:
0.00252
Gnomad NFE exome
AF:
0.00464
Gnomad OTH exome
AF:
0.00466
GnomAD4 exome
AF:
0.00477
AC:
6964
AN:
1459242
Hom.:
17
Cov.:
30
AF XY:
0.00467
AC XY:
3388
AN XY:
726002
show subpopulations
Gnomad4 AFR exome
AF:
0.000809
Gnomad4 AMR exome
AF:
0.00323
Gnomad4 ASJ exome
AF:
0.000422
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00291
Gnomad4 FIN exome
AF:
0.00313
Gnomad4 NFE exome
AF:
0.00547
Gnomad4 OTH exome
AF:
0.00455
GnomAD4 genome
AF:
0.00297
AC:
452
AN:
152070
Hom.:
2
Cov.:
32
AF XY:
0.00281
AC XY:
209
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.000699
Gnomad4 AMR
AF:
0.00328
Gnomad4 ASJ
AF:
0.000577
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00270
Gnomad4 FIN
AF:
0.00151
Gnomad4 NFE
AF:
0.00496
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00454
Hom.:
40
Bravo
AF:
0.00309
TwinsUK
AF:
0.00674
AC:
25
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.00105
AC:
4
ESP6500EA
AF:
0.00438
AC:
36
ExAC
AF:
0.00334
AC:
404
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00426
EpiControl
AF:
0.00445

ClinVar

Significance: Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2024RETREG1: BS2 -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 28, 2024- -
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 06, 2021- -
Neuropathy, hereditary sensory and autonomic, type 2B Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 28, 2023- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 15, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.023
.;T
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Benign
0.32
N
LIST_S2
Uncertain
0.92
D;D
MetaRNN
Benign
0.012
T;T
MetaSVM
Benign
-0.77
T
MutationTaster
Benign
0.96
D;D
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.2
N;N
REVEL
Benign
0.17
Sift
Benign
0.066
T;T
Sift4G
Benign
0.11
T;T
Polyphen
1.0
D;D
Vest4
0.27
MVP
0.47
MPC
1.0
ClinPred
0.015
T
GERP RS
5.1
Varity_R
0.12
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143878016; hg19: chr5-16481181; COSMIC: COSV99063742; COSMIC: COSV99063742; API